Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT00100854 · COMPLETED
Trial details
- NCT number
- NCT00100854
- Sponsor
- Translational Oncology Research International
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-28
- Primary completion
- 2018-09-05
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.